Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN)

[1] Shi C(2012)Intraductal papillary mucinous neoplasm Human Pathol. 43 1-16

[2] Hruban RH(2013)Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation Ann Surg Oncol. 20 440-447

[3] Lafemina J(2015)Premalignant cystic neoplasms of the pancreas Sem Oncol. 42 70-85

[4] Katabi N(2015)A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas Am J Surg Pathol. 39 1730-1741

[5] Klimstra D(2016)Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona consensus meeting Ann Surg. 263 162-177

[6] Correa-Gallego C(2012)International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Pancreatology. 12 183-197

[7] Gaujoux S(2016)Intraductal papillary mucinous neoplasm of the pancreas: current state of the art and ongoing controversies Ann Surg. 263 908-917

[8] Kingham TP(2007)Clinical importance of precursor lesions in the pancreas J Hepato-biliary-pancreat Surg. 14 255-263

[9] Dudeja V(2016)Therapeutic approach to cystic neoplasms of the pancreas Surg Oncol Clin N Am. 25 351-361

[10] Allen PJ(2007)Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm J Am Coll Surg. 204 987-993

[1] Shi C(2012)Intraductal papillary mucinous neoplasm Human Pathol. 43 1-16

[2] Hruban RH(2013)Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation Ann Surg Oncol. 20 440-447

[3] Lafemina J(2015)Premalignant cystic neoplasms of the pancreas Sem Oncol. 42 70-85

[4] Katabi N(2015)A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas Am J Surg Pathol. 39 1730-1741

[5] Klimstra D(2016)Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona consensus meeting Ann Surg. 263 162-177

[6] Correa-Gallego C(2012)International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Pancreatology. 12 183-197

[7] Gaujoux S(2016)Intraductal papillary mucinous neoplasm of the pancreas: current state of the art and ongoing controversies Ann Surg. 263 908-917

[8] Kingham TP(2007)Clinical importance of precursor lesions in the pancreas J Hepato-biliary-pancreat Surg. 14 255-263

[9] Dudeja V(2016)Therapeutic approach to cystic neoplasms of the pancreas Surg Oncol Clin N Am. 25 351-361

[10] Allen PJ(2007)Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm J Am Coll Surg. 204 987-993